These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6758457)

  • 1. Cell-mediated immunity and immune complexes in the pathogenesis of type 1 (insulin-dependent) diabetes.
    Pozzilli P; Di Mario U; Andreani D
    Acta Diabetol Lat; 1982; 19(4):295-300. PubMed ID: 6758457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Disorders of cellular immunity in insulin-dependent diabetes mellitus (type 1)].
    Korfel J
    Pol Tyg Lek; 1985 May; 40(18):527-30. PubMed ID: 3892515
    [No Abstract]   [Full Text] [Related]  

  • 3. Activating Fc gamma receptors participate in the development of autoimmune diabetes in NOD mice.
    Inoue Y; Kaifu T; Sugahara-Tobinai A; Nakamura A; Miyazaki J; Takai T
    J Immunol; 2007 Jul; 179(2):764-74. PubMed ID: 17617565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation between cellular and humoral immunity to islet cell antigens in type 1 diabetes.
    Hummel M; Durinovic-Bello I; Ziegler AG
    J Autoimmun; 1996 Jun; 9(3):427-30. PubMed ID: 8816982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular immune reactions against rat pancreatic islets mediated by antibodies from type I diabetic patients.
    Kruschel B; Jahr H; Marx S; Michaelis D
    Biomed Biochim Acta; 1984; 43(5):635-9. PubMed ID: 6383367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-mediated autoimmunity at the onset of insulin-dependent diabetes mellitus (IDDM).
    Ziegler AG; Standl E; Lander T; Nerl C; Rieber EP; Mehnert H
    Klin Wochenschr; 1987 Jul; 65(12):546-50. PubMed ID: 3306133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell mediated immunity to islet cells: lessons from animal studies.
    Kolb H; Kiesel U; Flohr K; Greulich B; Freytag G; Kolb-Bachofen V
    Behring Inst Mitt; 1984 Jul; (75):33-8. PubMed ID: 6385952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The autoimmune mechanisms of the development of insulin-dependent diabetes mellitus].
    Shishko PI
    Ter Arkh; 1991; 63(6):l46-51. PubMed ID: 1948721
    [No Abstract]   [Full Text] [Related]  

  • 9. Cell-mediated immune reactions against B cells and defect of suppressor cell activity in type 1 (insulin-dependent) diabetes mellitus.
    Lohmann D; Krug J; Lampeter EF; Bierwolf B; Verlohren HJ
    Diabetologia; 1986 Jul; 29(7):421-5. PubMed ID: 2943624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dynamics of a series of parameters of cellular and humoral immunity in patients with diabetes mellitus type I].
    Pometkin VV; Nikonova TV; Brykova SV
    Probl Endokrinol (Mosk); 1994; 40(6):5-7. PubMed ID: 7740039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell recognition of beta-cell autoantigens in insulin-dependent diabetes mellitus.
    Kallan AA; de Vries RR; Roep BO
    APMIS; 1996 Jan; 104(1):3-11. PubMed ID: 8645454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NKT cells inhibit the onset of diabetes by impairing the development of pathogenic T cells specific for pancreatic beta cells.
    Beaudoin L; Laloux V; Novak J; Lucas B; Lehuen A
    Immunity; 2002 Dec; 17(6):725-36. PubMed ID: 12479819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disordered cellular immunity in type I diabetes of man and the BB rat.
    Buse JB; Rowley RF; Eisenbarth GS
    Surv Immunol Res; 1982; 1(4):339-51. PubMed ID: 6227072
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibody-dependent cell-mediated cytotoxicity of mononuclear cells against Langerhans islets of Wistar rats in normal man and in patients at diabetes risk.
    Köhler E; Knospe S; Woltanski G; Maciejewski R; Salzsieder C; Rjasanowski I; Strese J; Michaelis D
    Biomed Biochim Acta; 1984; 43(5):627-33. PubMed ID: 6383366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer cell and islet killer cell activities in type 1 (insulin-dependent) diabetes.
    Negishi K; Waldeck N; Chandy G; Buckingham B; Kershnar A; Fisher L; Gupta S; Charles MA
    Diabetologia; 1986 Jun; 29(6):352-7. PubMed ID: 3527835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neither B lymphocytes nor antibodies directed against self antigens of the islets of Langerhans are required for development of virus-induced autoimmune diabetes.
    Holz A; Dyrberg T; Hagopian W; Homann D; von Herrath M; Oldstone MB
    J Immunol; 2000 Nov; 165(10):5945-53. PubMed ID: 11067957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of regulatory T cells in the pathogenesis of autoimmune diabetes.
    Arreaza GA; Sharif S; Cameron MJ; Chen W; Delovitch TL
    Curr Dir Autoimmun; 2001; 4():308-32. PubMed ID: 11569408
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibody-dependent and natural killer cytotoxicity in type 1 diabetes.
    Sensi M; Pozzilli P; Cudworth AG
    Acta Diabetol Lat; 1981; 18(4):339-44. PubMed ID: 7331674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immuno- and regeneration therapy of recently diagnosed diabetes mellitus type I].
    Huth E
    Klin Padiatr; 1985; 197(2):75-84. PubMed ID: 3157826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell-mediated autoimmunity may be involved in fulminant type 1 diabetes.
    Shimada A; Morimoto J; Kodama K; Oikawa Y; Irie J; Nakagawa Y; Narumi S; Saruta T
    Diabetes Care; 2002 Mar; 25(3):635-6. PubMed ID: 11874969
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.